"Designing Growth Strategies is in our DNA"

U.S. Point of Care Diagnostics Market Size, Share & Industry Analysis, By Product (Blood Glucose Monitoring, Infectious Disease Testing, Cardiometabolic Disease Testing, Pregnancy & Fertility Testing, Hematology Testing, and Others), By Sample (Blood, Nasal and Oropharyngeal Swabs, Urine, and Others), By End-user (Hospital Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, and Homecare/Self-Testing), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108003

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Disease Indications in the U.S., 2023
    2. Technological Advancements in the Point of Care Diagnostics
    3. New Product Launches, Key Players
    4. Overview of Regulatory Scenario in the U.S.
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    6. Overview of COVID-19 Impact on U.S. Point of Care Diagnostics Market
  5. U.S. Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Blood Glucose Monitoring
      2. Infectious Diseases
      3. Cardiometabolic Diseases
      4. Pregnancy & Infertility Testing
      5. Hematology Testing
      6. Others
    2. Market Analysis, Insights and Forecast – By Sample
      1. Blood
      2. Nasal and Oropharyngeal Swabs
      3. Urine
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician’s Office Lab
      3. Urgent Care & Retail Clinics
      4. Homecare/Self-testing
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Abbott Laboratories
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Quest Diagnostics Incorporated
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. BD
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. bioMérieux SA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Cardinal Health, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Cepheid
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Trinity Biotech
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Quidel Corporation
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      11. Bio-Rad Laboratories Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      12. Other Prominent Players
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Disease Indications in the U.S., 2023
    2. Technological Advancements in the Point of Care Diagnostics
    3. New Product Launches, Key Players
    4. Overview of Regulatory Scenario in the U.S.
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    6. Overview of COVID-19 Impact on U.S. Point of Care Diagnostics Market
  5. U.S. Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Blood Glucose Monitoring
      2. Infectious Diseases
      3. Cardiometabolic Diseases
      4. Pregnancy & Infertility Testing
      5. Hematology Testing
      6. Others
    2. Market Analysis, Insights and Forecast – By Sample
      1. Blood
      2. Nasal and Oropharyngeal Swabs
      3. Urine
      4. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician’s Office Lab
      3. Urgent Care & Retail Clinics
      4. Homecare/Self-testing
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Abbott Laboratories
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Quest Diagnostics Incorporated
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. BD
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. bioMérieux SA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Cardinal Health, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Cepheid
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Trinity Biotech
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Quidel Corporation
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      11. Bio-Rad Laboratories Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      12. Other Prominent Players
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. Point of Care Diagnostics Market Revenue Breakdown (USD billion,%) by Product, 2023 & 2032

Figure 2:  U.S. Point of Care Diagnostics Market Value Share (%), by Product, 2023 & 2032

Figure 3:  U.S. Point of Care Diagnostics Market Value Share (%), by Sample, 2023 & 2032

Figure 4:  U.S. Point of Care Diagnostics Market Value Share (%), by End User, 2023 & 2032

Table 1:  U.S. Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 2:  U.S. Point of Care Diagnostics Market Revenue (USD billion) Forecast, by Sample, 2019–2032

Table 3:  U.S. Point of Care Diagnostics Market Revenue (USD billion) Forecast, by End User, 2019–2032

U.S. Point of Care Diagnostics Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 0
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports